- Home
- CCCC vs FSP Comparison
CCCC vs FSP Comparison
Compare CCCC & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- FSP
- Stock Information
- Founded
- CCCC 2015
- FSP 1981
- Country
- CCCC United States
- FSP United States
- Employees
- CCCC N/A
- FSP N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- FSP Real Estate Investment Trusts
- Sector
- CCCC Health Care
- FSP Real Estate
- Exchange
- CCCC Nasdaq
- FSP Nasdaq
- Market Cap
- CCCC 160.1M
- FSP 165.9M
- IPO Year
- CCCC 2020
- FSP N/A
- Fundamental
- Price
- CCCC $2.46
- FSP $1.42
- Analyst Decision
- CCCC Strong Buy
- FSP
- Analyst Count
- CCCC 4
- FSP 0
- Target Price
- CCCC $8.50
- FSP N/A
- AVG Volume (30 Days)
- CCCC 2.9M
- FSP 522.6K
- Earning Date
- CCCC 11-03-2025
- FSP 10-28-2025
- Dividend Yield
- CCCC N/A
- FSP 2.80%
- EPS Growth
- CCCC N/A
- FSP N/A
- EPS
- CCCC N/A
- FSP N/A
- Revenue
- CCCC $34,240,000.00
- FSP $111,879,000.00
- Revenue This Year
- CCCC N/A
- FSP $4.36
- Revenue Next Year
- CCCC N/A
- FSP $0.81
- P/E Ratio
- CCCC N/A
- FSP N/A
- Revenue Growth
- CCCC 16.55
- FSP N/A
- 52 Week Low
- CCCC $1.09
- FSP $1.36
- 52 Week High
- CCCC $6.52
- FSP $2.21
- Technical
- Relative Strength Index (RSI)
- CCCC 51.01
- FSP 29.30
- Support Level
- CCCC $2.31
- FSP $1.58
- Resistance Level
- CCCC $2.82
- FSP $1.49
- Average True Range (ATR)
- CCCC 0.22
- FSP 0.05
- MACD
- CCCC 0.03
- FSP -0.02
- Stochastic Oscillator
- CCCC 52.41
- FSP 12.50
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.